HK1069533A1 - Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups - Google Patents
Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groupsInfo
- Publication number
- HK1069533A1 HK1069533A1 HK05102131A HK05102131A HK1069533A1 HK 1069533 A1 HK1069533 A1 HK 1069533A1 HK 05102131 A HK05102131 A HK 05102131A HK 05102131 A HK05102131 A HK 05102131A HK 1069533 A1 HK1069533 A1 HK 1069533A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polyacrylate
- contact
- functional groups
- system based
- therapeutic system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10141652A DE10141652B4 (de) | 2001-08-24 | 2001-08-24 | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
PCT/EP2002/009057 WO2003017988A1 (de) | 2001-08-24 | 2002-08-13 | Transdermales therapeutisches system auf der basis von polyacrylat-haftklebern ohne funktionelle gruppen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1069533A1 true HK1069533A1 (en) | 2005-05-27 |
Family
ID=7696570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05102131A HK1069533A1 (en) | 2001-08-24 | 2005-03-11 | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040241219A1 (zh) |
EP (1) | EP1418895B1 (zh) |
JP (1) | JP4393188B2 (zh) |
KR (1) | KR100920599B1 (zh) |
CN (1) | CN1239153C (zh) |
AU (1) | AU2002327831B2 (zh) |
BR (1) | BRPI0211993B8 (zh) |
CA (1) | CA2455064C (zh) |
DE (1) | DE10141652B4 (zh) |
ES (1) | ES2397920T3 (zh) |
HK (1) | HK1069533A1 (zh) |
MX (1) | MXPA04001677A (zh) |
WO (1) | WO2003017988A1 (zh) |
ZA (1) | ZA200400312B (zh) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100940245B1 (ko) | 2000-09-19 | 2010-02-04 | 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 | 경피 약물 전달 시스템에 유용한 비반응성 접착제 |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
CN100508976C (zh) * | 2003-07-24 | 2009-07-08 | 史密丝克莱恩比彻姆公司 | 口腔溶解薄膜 |
EP1741448B1 (en) * | 2004-04-13 | 2012-10-03 | Nipro Patch Co., Ltd. | Crosslinkable pressure-sensitive adhesive for the skin |
CN1329022C (zh) * | 2004-08-31 | 2007-08-01 | 贵州太和制药有限公司 | 亲水性生物粘附凝胶贴剂及其制备工艺 |
CN101171053B (zh) * | 2005-03-12 | 2012-09-05 | 荷兰联合利华有限公司 | 结合有维司那定的头发和/或头皮护理组合物 |
CN1326894C (zh) * | 2005-03-24 | 2007-07-18 | 上海交通大学 | 包含酯基部分带烷氧基的丙烯酸酯的组合物 |
CN1320005C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带烷烃基的丙烯酸酯的组合物 |
CN1320008C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带羧基基团的丙烯酸酯的组合物 |
CN1320006C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带酯基基团的丙烯酸酯的组合物 |
CN1320009C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带羟基基团的丙烯酸酯的组合物 |
DE102006050558B4 (de) | 2006-10-26 | 2009-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution |
KR100956023B1 (ko) * | 2007-09-28 | 2010-05-06 | 대화제약 주식회사 | 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제 |
DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
WO2011076621A2 (de) * | 2009-12-22 | 2011-06-30 | Acino Ag | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
CN101967213A (zh) * | 2010-09-29 | 2011-02-09 | 北京化工大学 | 低分子量带有羧基的聚丙烯酸酯丙烯酸酯的制备方法 |
SI2468274T1 (sl) | 2010-12-14 | 2015-10-30 | Acino Ag | Transdermalni terapevtski sistem za dajanje aktivne snovi |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
JP6912876B2 (ja) * | 2016-10-06 | 2021-08-04 | 三洋化成工業株式会社 | アクリル系医薬固形製剤用添加剤 |
DE102017115701B4 (de) * | 2017-07-12 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Fampridin-TTS |
WO2019068288A1 (de) | 2017-10-04 | 2019-04-11 | Berlimed International Research Gmbh | Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung |
DE102018130469A1 (de) | 2018-11-30 | 2020-06-04 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Diffusionsbarriere |
DE102019120403A1 (de) | 2019-07-29 | 2021-02-04 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
CA2065311C (en) * | 1989-09-08 | 2000-01-11 | Chia-Ming Chiang | Solid matrix system for transdermal drug delivery |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
CA2039586A1 (en) * | 1990-05-02 | 1991-11-03 | Marian R. Appelt | Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same |
IT1253265B (it) * | 1991-11-25 | 1995-07-14 | Rotta Research Lab | Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo. |
JPH07501465A (ja) * | 1991-11-26 | 1995-02-16 | リサーチ ディベロップメント ファンデーション | 神経および血管移植用胎児膜チューブ |
DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
DE59405277D1 (de) * | 1993-04-20 | 1998-03-26 | Hexal Ag | Wirkstoffplaster |
EP0707465A4 (en) * | 1993-07-08 | 1997-04-16 | Cygnus Therapeutic Systems | MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM |
US5554381A (en) * | 1993-08-09 | 1996-09-10 | Cygnus, Inc. | Low flux matrix system for delivering potent drugs transdermally |
ES2122140T3 (es) * | 1993-12-30 | 1998-12-16 | Rotta Res Bv | Parche transdermico con dinitrato de isosorbida como ingrediente activo. |
DE4403487C2 (de) * | 1994-02-04 | 2003-10-16 | Lohmann Therapie Syst Lts | Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren |
US5614210A (en) * | 1995-03-31 | 1997-03-25 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of alfuzosin |
SE504430C2 (sv) | 1995-06-20 | 1997-02-10 | Ericsson Telefon Ab L M | Magasin |
JPH1036265A (ja) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
US5928666A (en) * | 1996-11-12 | 1999-07-27 | Cygnus Inc. | Crystalline form of estradiol and pharmaceutical formulations comprising same |
US6210705B1 (en) * | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
DE19830651A1 (de) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung |
CA2331264C (en) * | 1999-01-14 | 2008-09-23 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
DE50009346D1 (de) * | 1999-11-29 | 2005-03-03 | Novosis Ag | Transdermalsystem zur Abgabe von Clonidin |
DE10032537A1 (de) * | 2000-07-05 | 2002-01-31 | Labtec Gmbh | Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure |
KR100940245B1 (ko) * | 2000-09-19 | 2010-02-04 | 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 | 경피 약물 전달 시스템에 유용한 비반응성 접착제 |
-
2001
- 2001-08-24 DE DE10141652A patent/DE10141652B4/de not_active Expired - Lifetime
-
2002
- 2002-08-13 CA CA2455064A patent/CA2455064C/en not_active Expired - Lifetime
- 2002-08-13 JP JP2003522508A patent/JP4393188B2/ja not_active Expired - Fee Related
- 2002-08-13 MX MXPA04001677A patent/MXPA04001677A/es active IP Right Grant
- 2002-08-13 EP EP02762444A patent/EP1418895B1/de not_active Revoked
- 2002-08-13 WO PCT/EP2002/009057 patent/WO2003017988A1/de active Application Filing
- 2002-08-13 AU AU2002327831A patent/AU2002327831B2/en not_active Ceased
- 2002-08-13 BR BRPI0211993A patent/BRPI0211993B8/pt not_active IP Right Cessation
- 2002-08-13 CN CNB028164385A patent/CN1239153C/zh not_active Expired - Fee Related
- 2002-08-13 KR KR1020047002667A patent/KR100920599B1/ko active IP Right Grant
- 2002-08-13 US US10/487,380 patent/US20040241219A1/en not_active Abandoned
- 2002-08-13 ES ES02762444T patent/ES2397920T3/es not_active Expired - Lifetime
-
2004
- 2004-01-15 ZA ZA200400312A patent/ZA200400312B/en unknown
-
2005
- 2005-03-11 HK HK05102131A patent/HK1069533A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE10141652A1 (de) | 2003-03-13 |
EP1418895A1 (de) | 2004-05-19 |
KR20040044477A (ko) | 2004-05-28 |
BRPI0211993B8 (pt) | 2021-07-27 |
JP2005503390A (ja) | 2005-02-03 |
CA2455064A1 (en) | 2003-03-06 |
BRPI0211993B1 (pt) | 2017-04-11 |
CN1239153C (zh) | 2006-02-01 |
CN1545408A (zh) | 2004-11-10 |
US20040241219A1 (en) | 2004-12-02 |
EP1418895B1 (de) | 2012-12-19 |
DE10141652B4 (de) | 2011-04-07 |
ES2397920T3 (es) | 2013-03-12 |
JP4393188B2 (ja) | 2010-01-06 |
CA2455064C (en) | 2010-08-03 |
ZA200400312B (en) | 2004-11-01 |
WO2003017988A1 (de) | 2003-03-06 |
KR100920599B1 (ko) | 2009-10-08 |
MXPA04001677A (es) | 2004-05-31 |
BR0211993A (pt) | 2004-09-28 |
AU2002327831B2 (en) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069533A1 (en) | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups | |
AU2002327831A1 (en) | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups | |
PL352550A1 (en) | Transdermal therapeutic system employing neutralised pressure-sensitive acrylic adesives | |
AU2002258186A1 (en) | Iontophoresis device | |
IL166808A0 (en) | Catheter securement device | |
AU2003263000A1 (en) | Catheter anchor system | |
AU2003247858A8 (en) | Improved cannula system | |
AU2003213659A1 (en) | Medical clip applier safety arrangement | |
AU2003261085A1 (en) | Single system user identity | |
AU2003256813A8 (en) | Medical tele-robotic system | |
AU2002328328A1 (en) | Transdermal therapeutic system with fentanyl or related substances | |
AU148333S (en) | Adhesive bandage | |
AU2002210463A1 (en) | Transdermal therapeutic system | |
AU2002952124A0 (en) | Personal device fastening system | |
AU2002353444A1 (en) | Integrated transdermal drug delivery system | |
AU2002332083A8 (en) | Guide-in-guide catheter system | |
HUP0500013A3 (en) | Infusion system | |
EP1422743A4 (en) | TREATMENT SYSTEM | |
AU2003241134A1 (en) | Transdermal drug delivery system | |
AU2003201863A1 (en) | Potential therapeutic device | |
AU2002329530A1 (en) | Transdermal delivery system | |
AU2002362214A1 (en) | Physical therapy device | |
AUPR877101A0 (en) | Transdermal delivery system | |
GB0214012D0 (en) | Transdermal delivery system | |
AUPR946301A0 (en) | Transdermal therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140813 |